You are here: Home » Markets » News
Business Standard

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

The Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent higher led by Infosys and NIIT Tech

SI Reporter  |  New Delhi 

Markets, Up, Down, BSE, NSE, Stocks
Photo: Shutterstock.com

The benchmark indices settled 0.5 per cent higher on Monday led by market heavyweights Reliance Industries, Sun Pharma and select information technology (IT) and private bank stocks.

The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent.

Among sectoral indices, the Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent led by Infosys and NIIT Technologies.

In the broader market, S&P BSE MidCap index slipped 84 points or 0.56 per cent to settle at 14,939, while S&P BSE SmallCap index ended at 14,402, down 102 points or 0.70 per cent.

Buzzing Stocks

Shares of Reliance Industries (RIL) rose 4.36 per cent to end the day at Rs 1,234.50 apiece on Monday. The stock gained nine per cent in the past two trading days on BSE, after the company reported a better-than-expected consolidated net profit of Rs 10,251 crore in October-December quarter (Q3FY19). The company had logged profit of Rs 9,420 crore in the year-ago quarter.

Shares of Sun Pharmaceutical Industries gained 1.94 per cent to settle at Rs 398.35 apiece on the BSE on Monday, after the pharmaceutical firm urged markets regulator Sebi to examine the role of some media houses with respect to the reports of fresh whistleblower complaints.

Global Markets

Asian markets kept their nerve on Monday as data showed the Chinese economy slowed at the end of last year, underlining the urgent need for more stimulus as Beijing wrestles with the United States over trade.

Markets reacted calmly, with MSCI’s broadest index of Asia-Pacific shares outside Japan up 0.2 per cent, after rising 1.6 per cent last week. Chinese blue chips gained 0.7 per cent. Japan's Nikkei added 0.3 per cent, helped by a recent pullback in the yen.

(with Reuters input)

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Top sectoral gainers and losers on NSE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

S&P BSE Sensex: Top gainers and losers

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Market at close The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent.

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Reliance Industries gains 9% in two days post December quarter results Shares of Reliance Industries (RIL) were quoting higher by 4.4 per cent at Rs 1,237 apiece at the fag-end of the trading session on Monday , gaining nine per cent in the past two trading days on BSE, after the company reported a better-than-expected consolidated net profit of Rs 10,251 crore in October-December quarter (Q3FY19). The company had logged profit of Rs 9,420 crore in the year-ago quarter. READ MORE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Union Bank declines 5% post Q3 results announcement Shares of Union Bank plunged as much as 5 per cent in the intra-day deals on Monday after the lender reported net profit of Rs 153.2 crore for October-December quarter of FY19. The bank had posted loss of Rs 1,250 crore in the year-ago period.   Percentage wise, net NPAs came in at 8.27 per cent against 8.42 per cent in the September quarter. In the year-ago quarter, numbers stood at 6.96 per cent. Net interest income (NII) fell 2.1 per cent YoY. READ MORE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

NEWS ALERT Hind Zinc Q3FY19 net profit at Rs 2,211 crores vs Rs 2,298 in Q3FY18

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Top gainers on BSE500 COMPANY PRICE() CHG() CHG(%) VOLUME SPARC 168.15 19.75 13.31 1307057 ITI 111.80 7.40 7.09 854733 TAKE SOLUTIONS 162.95 8.40 5.44 54518 TIME TECHNOPLAST 106.00 5.30 5.26 56458 UNITED BREWERIES 1479.25 66.00 4.67 40201 » More on Top Gainers

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

LIC completes the acquisition of 51% controlling stake in IDBI Bank IDBI Bank Monday said insurance behemoth LIC has completed acquisition of 51 per cent controlling stake in the bank, making it the lender's majority shareholder. "The deal, conceptualised in June 2018, is envisaged as a win-win situation for both IDBI Bank and LIC with an opportunity to create enormous value for shareholders, customers & employees of both entities through mutual synergies," IDBI Bank said in a BSE filing. Read more  

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Earnings Impact

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

NEWS ALERT | Union Bank reports net profit at Rs 153.2 cr vs Rs 139.03 cr on QoQ

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Goldman Sachs expects RBI to cut rates by a quarter percentage point in Feb Goldman Sachs Group Inc. expects India’s central bank to cut interest rates by a quarter percentage point in February, the latest to add its voice to a chorus of calls for monetary policy easing. The Wall Street bank said lower inflation projections, and expectations of a slower pace of U.S. policy rate hikes prompted it to shift its call from a previous forecast of no change in February. Read more A view of the Goldman Sachs stall on the floor of the New York Stock Exchange in New York (Photo: Reuters)

First Published: Mon, January 21 2019. 08:16 IST
RECOMMENDED FOR YOU

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

The Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent higher led by Infosys and NIIT Tech

The benchmark indices settled 0.5 per cent higher on Monday led by market heavyweights Reliance Industries, Sun Pharma and select information technology (IT) and private bank stocks.

The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent.

Among sectoral indices, the Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent led by Infosys and NIIT Technologies.

In the broader market, S&P BSE MidCap index slipped 84 points or 0.56 per cent to settle at 14,939, while S&P BSE SmallCap index ended at 14,402, down 102 points or 0.70 per cent.

Buzzing Stocks

Shares of Reliance Industries (RIL) rose 4.36 per cent to end the day at Rs 1,234.50 apiece on Monday. The stock gained nine per cent in the past two trading days on BSE, after the company reported a better-than-expected consolidated net profit of Rs 10,251 crore in October-December quarter (Q3FY19). The company had logged profit of Rs 9,420 crore in the year-ago quarter.

Shares of Sun Pharmaceutical Industries gained 1.94 per cent to settle at Rs 398.35 apiece on the BSE on Monday, after the pharmaceutical firm urged markets regulator Sebi to examine the role of some media houses with respect to the reports of fresh whistleblower complaints.

Global Markets

Asian markets kept their nerve on Monday as data showed the Chinese economy slowed at the end of last year, underlining the urgent need for more stimulus as Beijing wrestles with the United States over trade.

Markets reacted calmly, with MSCI’s broadest index of Asia-Pacific shares outside Japan up 0.2 per cent, after rising 1.6 per cent last week. Chinese blue chips gained 0.7 per cent. Japan's Nikkei added 0.3 per cent, helped by a recent pullback in the yen.

(with Reuters input)

image
Business Standard
177 22